Masson, E., Relling, M. V., Synold, T. W., Liu, Q., Schuetz, J. D., Sandlund, J. T., . . . Evans, W. E. (1996). Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.

Masson, E., M V. Relling, T W. Synold, Q. Liu, J D. Schuetz, J T. Sandlund, C H. Pui, and W E. Evans. Accumulation of Methotrexate Polyglutamates in Lymphoblasts Is a Determinant of Antileukemic Effects in Vivo. A Rationale for High-dose Methotrexate. 1996.

Masson, E., et al. Accumulation of Methotrexate Polyglutamates in Lymphoblasts Is a Determinant of Antileukemic Effects in Vivo. A Rationale for High-dose Methotrexate. 1996.